Time‐Dependent Thermocontrol of the Hydrophilic and Lipophilic Properties of DNA Oligonucleotide Prodrugs
互联网
2031
- Abstract
- Table of Contents
- Materials
- Figures
- Literature Cited
Abstract
This unit describes the preparation of alkylthioalkylated and formamidoalkylated alcohols, an amidoalkylated alcohol, a hydroxylalkylated phosphoramidate, and their phosphoramidothioate derivatives, all of which have been identified as heat?sensitive thiophosphate?protecting groups in the development of thermolytic immunostimulatory DNA prodrugs. The alcohols are converted to their deoxyribonucleoside phosphoramidite derivatives, which are then used in the preparation of thermosensitive dinucleoside phosphorothioates. The thiophosphate?protecting groups of these dinucleoside phosphorothioates presumably undergo thermolytic cyclodeesterification at elevated temperature under essentially neutral conditions to release the desired phosphorothioate diester function. On the basis of their thermolytic deprotection kinetics, one can identify those thiophosphate?protecting groups that (i) may be useful for thiophosphate protection of CpG motifs of immunostimulatory DNA oligonucleotides (CpG ODNs); (ii) are suitable for protection of phosphodiester functions flanking the CpG motifs; and (iii) offer adequate protection of terminal phosphodiester functions against ubiquitous extracellular and intracellular exonucleases that may be found in biological environments. Curr. Protoc. Nucleic Acid Chem. 43:4.42.1?4.42.31. © 2010 by John Wiley & Sons, Inc.
Keywords: oligonucleotide prodrugs; thiophosphate protecting groups; thermolytic deprotection; thermolytic conditions; solid?phase oligonucleotide synthesis; CpG ODNs; lipophilicity; hydrophilicity
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online LibraryTable of Contents
- Introduction
- Basic Protocol 1: Synthesis, Purification, and Characterization of Alkylthioalkylated Alcohols
- Basic Protocol 2: Synthesis, Purification, and Characterization of Formamidoalkylated Alcohols
- Basic Protocol 3: Synthesis, Purification, and Characterization of Hydroxyalkylated Phosphoramidate and Phosphoramidothioate Derivatives
- Basic Protocol 4: Synthesis, Purification, and Characterization of Alkylthioalkylated, Formamidoalkylated, Phosphoramidated, and Phosphoramidothioated Deoxyribonucleoside Phosphoramidite Derivatives
- Basic Protocol 5: Solid‐Phase Synthesis of Thermosensitive Dinucleoside Phosphorothioate Triesters and Their Conversion to Phosphorothioate Diesters Under Thermolytic Conditions
- Basic Protocol 6: Automated Solid‐Phase Synthesis of a Heat‐Sensitive DNA Prodrug Model and Its Selective Thermolytic Deprotection
- Commentary
- Literature Cited
- Figures
- Tables
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online LibraryMaterials
Basic Protocol 1: Synthesis, Purification, and Characterization of Alkylthioalkylated Alcohols
Materials
Basic Protocol 2: Synthesis, Purification, and Characterization of Formamidoalkylated Alcohols
Materials
Basic Protocol 3: Synthesis, Purification, and Characterization of Hydroxyalkylated Phosphoramidate and Phosphoramidothioate Derivatives
Materials
Basic Protocol 4: Synthesis, Purification, and Characterization of Alkylthioalkylated, Formamidoalkylated, Phosphoramidated, and Phosphoramidothioated Deoxyribonucleoside Phosphoramidite Derivatives
Materials
Basic Protocol 5: Solid‐Phase Synthesis of Thermosensitive Dinucleoside Phosphorothioate Triesters and Their Conversion to Phosphorothioate Diesters Under Thermolytic Conditions
Materials
Basic Protocol 6: Automated Solid‐Phase Synthesis of a Heat‐Sensitive DNA Prodrug Model and Its Selective Thermolytic Deprotection
Materials
|
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online LibraryFigures
-
Figure 4.42.1 Synthesis of 5‐(methylthio)pentan‐1‐ol (S.5 ) and 5‐(isopropylthio)pentan‐1‐ol (S.6 ) from methyl 5‐chlorovalerate. See Brown et al. () for the preparation of (CH3 )2 CHSNa. Reprinted from Ausín et al. () with permission from Elsevier. View Image -
Figure 4.42.2 Synthesis of 4‐(trifluoromethylthio)butan‐1‐ol (S.7 ) from the reaction of 4‐mercaptobutan‐1‐ol with 1‐trifluoromethyl‐1,3‐dihydro‐3,3‐dimethyl‐1,2‐benziodoxole. Reprinted from Ausín et al. () with permission from Elsevier. View Image -
Figure 4.42.3 Preparation of 4‐(methoxymethylthio)butan‐1‐ol (S.8 ) from 4‐mercaptobutan‐1‐ol. Reprinted from Ausín et al. () with permission from Elsevier. View Image -
Figure 4.42.4 Preparation of 2‐(2‐methylthioethoxy)ethanol (S.9 ) from 2‐(methylthio)ethanol (S.2 ). Reprinted from Ausín et al. () with permission from Elsevier. View Image -
Figure 4.42.5 Synthesis of 3‐(methylthiomethoxy)propan‐1‐ol (S.10 ) and 2‐(methylthiomethoxy)ethanol (S.11 ) from methythiomethyl acetate. Reprinted from Ausín et al. () with permission from Elsevier. View Image -
Figure 4.42.6 Preparation of 3‐( N ‐formyl‐ N ‐methylamino)propan‐1‐ol (S.13 ) from 3‐aminopropan‐1‐ol. Reprinted from Ausín et al. () with permission from Elsevier. View Image -
Figure 4.42.7 General synthesis of the hydroxyalkylated phosphoramidate (S.19 ) and phosphoramidothioate derivatives (S.20 ‐S.25 ). Abbreviations: DMTr, 4,4′‐dimethoxytrityl; Et, ethyl; i ‐Pr, isopropyl; N(CH2 CH2 )2 O, morpholinyl. Adapted from Grajkowski et al. (). Reproduced by permission of the Royal Society of Chemistry (RSC) for the Centre National de la Recherche Scientifique (CNRS) and the RSC. View Image -
Figure 4.42.8 Preparation of the deoxyribonucleoside phosphoramidites S.27 ‐S.48 . Abbreviations: CE, 2‐cyanoethyl; DMTr, 4,4′‐dimethoxytrityl; Et, ethyl; i ‐Pr, isopropyl; Thy, thymin‐1‐yl; N(CH2 CH2 )2 O, morpholinyl. Adapted from Ausín et al. () with permission from Elsevier, and from Grajkowski et al. () with permission from the Royal Society of Chemistry. View Image -
Figure 4.42.9 Solid‐phase synthesis of dinucleoside phosphorothioate triesters S.50 ‐S.71 and removal of the thiophosphate protecting groups under thermolytic conditions. Abbreviations: CPG, long‐chain alkylamine controlled‐pore glass; DMTr, 4,4′‐dimethoxytrityl; R, thermosensitive thiophosphate‐protecting groups derived from S.1 ‐S.15 and S.19 ‐S.25 ; Thy, thymin‐1‐yl. Adapted from Ausín et al. () with permission from Elsevier, and from Grajkowski et al. () with permission from the Royal Society of Chemistry. View Image -
Figure 4.42.10 PAGE analysis of the thermolytic deprotection of DNA oligonucleotide S.72 under denaturing conditions. Left lane: RP‐HPLC‐purified control DNA S.73 . Right lane: RP‐HPLC‐purified DNA S.72 heated in PBS (pH 7.4) for 3 hr at 90°C. Oligonucleotides were visualized as blue bands after staining with Stains‐All. Bromphenol blue was used as a marker and shows as a large band at the bottom of the gel in each lane. Reprinted from Ausín et al. () with permission from Elsevier. View Image -
Figure 4.42.11 Relative solubility of DNA oligonucleotide S.72 upon thermal deprotection of the fma thiophosphate‐protecting groups. 100% relative solubility is defined as the maximum absorbance ( A max ) of the DNA sequence at 268 nm and 90°C. Thus, % relative solubility = ( A / A max ) × 100 for each time point. Reprinted from Ausìn et al. () with permission from Elsevier. View Image
Videos
Literature Cited
| Literature Cited | |
| Ausín, C., Kauffman, J.S., Duff, R.J., Shivaprasad, S., and Beaucage, S.L. 2010. Assessment of heat‐sensitive thiophosphate protecting group in the development of thermolytic DNA oligonucleotide prodrugs. Tetrahedron 66:68‐79. | |
| Bannwarth, W., Dorn, A., Iaiza, P., and Pannekouke, X. 1994. Short optimally capped duplex DNA as conformationally restricted analog of B‐DNA. Helv. Chim. Acta 77:182‐193. | |
| Barber, I., Rayner, B., and Imbach, J.‐L. 1995. The prooligonucleotide approach. I: Esterase‐mediated reversibility of dithymidine‐S‐alkyl‐phosphorothiolates to dithymidine phosphorothioates. Bioorg. Med. Chem. Lett. 5:563‐568. | |
| Boal, J.H., Wilk, A., Harindranath, N., Max, E.E., Kempe, T., and Beaucage, S.L. 1996. Cleavage of oligodeoxyribonucleotides from controlled pore glass supports and their rapid deprotection by gaseous amines. Nucleic Acids Res. 24:3115‐3117. | |
| Bologna, J.‐C., Vivès, E., Imbach, J.‐L., and Morvan, F. 2002. Uptake and quantification of intracellular concentration of lipophilic pro‐oligonucleotides in HeLa cells. Antisense Nucleic Acid Drug Dev. 12:33‐41. | |
| Bongartz, J.‐P., Aubertin, A.‐M., Milhaud, P.G., and Lebleu, B. 1994. Improved biological activity of antisense oligonucleotides conjugated to a fusogenic peptide. Nucleic Acids Res. 22:4681‐4688. | |
| Brown, E.D., Iqbal, S.M., and Owen, L.N. 1966. The reductive fission of methyl sulphides, 1,3‐dithiolans, and a 1,3‐oxathiolan by sodium in liquid ammonia. J. Chem. Soc. C 1966:415‐419. | |
| Chang, Y.‐C., Herath, J., Wang, T.‐H.H., and Chow, C.‐S. 2008. Synthesis and solution conformation studies of 3‐substituted uridine and pseudouridine derivatives. Bioorg. Chem. Med. 16:2676‐2686. | |
| Deslongchamps, P., Cheriyan, U.O., and Taillefer, R.J. 1979. Hydrolysis of cyclic unsymmetrical anti imidate salts. New evidence for stereoelectronic control. Can. J. Chem. 57:3262‐3271. | |
| Ferreira, F., Meyer, A., Vasseur, J.‐J., and Morvan, F. 2005. Universal solid supports for the synthesis of oligonucleotides via a transesterification of H‐phosphonate diester linkage. J. Org. Chem. 70:9198‐9206. | |
| Grajkowski, A., Wilk, A., Chmielewski, M.K., Phillips, L.R., and Beaucage, S.L. 2001. The 2‐(N‐formyl‐N‐methyl) aminoethyl group as a potential phosphate/thiophosphate protecting group in solid‐phase oligodeoxyribonucleotide synthesis. Org. Lett. 3:1287‐1290. | |
| Grajkowski, A., Pedras‐Vasconcelos, J., Wang, V., Ausín, C., Hess, S., Verthelyi, D., and Beaucage, S.L. 2005. Thermolytic CpG‐containing DNA oligonucleotides as potential immunotherapeutic prodrugs. Nucleic Acids Res. 33:3550‐3560. | |
| Grajkowski, A., Cieślak, J., Kauffman, J.S., Duff, R.J., Norris, S., Freedberg, D.I., and Beaucage, S.L. 2008. Thermolytic release of covalently linked DNA oligonucleotides and their conjugates from controlled‐pore glass at near neutral pH. Bioconjug. Chem. 19:1696‐1706. | |
| Grajkowski, A., Cieślak, J., Gapeev, A., and Beaucage, S.L. 2010. Hydroxylated phosphoramidate, phosphoramidothioate and phosphorodiamidothioate derivatives as thiophosphate protecting groups in the development of thermolytic DNA prodrugs. New J. Chem. 34:880‐887. | |
| Greenberg, M.M., Matray, T.J., Kahl, J.D., Yoo, D.J., and McMinn, D.L. 1998. Optimization and mechanistic analysis of oligonucleotide cleavage from palladium‐labile solid‐phase synthesis supports. J. Org. Chem. 63:4062‐4068. | |
| Guan, J., Kyle, D.E., Gerena, L., Zhang, Q., Milhous, W.K., and Lin, A.J. 2002. Design, synthesis, and evaluation of new chemosensitizers in multi‐drug‐resistant Plasmodium falciparum. J. Med. Chem. 45:2741‐2748. | |
| Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., and Akira, S. 2000. A Toll‐like receptor recognizes bacterial DNA. Nature 408:740‐745. | |
| Iyer, R.P., Phillips, L.R., Egan, W., Regan, J.B., and Beaucage, S.L. 1990. The automated synthesis of sulfur‐containing oligodeoxyribonucleotides using 3H‐1,2‐benzodithiol‐3‐one‐1,1‐dioxide as a sulfur‐transfer reagent. J. Org. Chem. 55:4693‐4699. | |
| Iyer, R.P., Yu, D., and Agrawal, S. 1994. Stereospecific bio‐reversibility of dinucleoside S‐alkyl phosphorothiolates to dinucleoside phosphorothioates. Bioorg. Med. Chem. Lett. 4:2471‐2476. | |
| Iyer, R.P., Ho, N.H., Yu, D., and Agrawal, S. 1997. Bioreversible oligonucleotide conjugates by site‐specific derivatization. Bioorg. Med. Chem. Lett. 7:871‐876. | |
| Jones, S.S., Reese, C.B., and Sibanda, S. 1981. The 2‐(methylthiomethoxy)ethoxycarbonyl [mtmec] protecting group. Tetrahedron Lett. 22:1933‐1936. | |
| Kieltsch, I., Eisenberger, P., and Togni, A. 2007. Mild electrophilic trifluoromethylation of carbon‐ and sulfur‐centered nucleophiles by a hypervalent iodine(III)‐CF3 reagent. Angew. Chem. Int. Ed. 46:754‐757. | |
| Klinman, D.M., Takeshita, F., Gursel, I., Leifer, C., Ishii, K.J., Verthelyi, D., and Gursel, M. 2002. CpG DNA: Recognition by and activation of monocytes. Microbes Infect. 4:897‐901. | |
| Koepke, S.R., Kupper, R., and Michejda, C.J. 1979. Unusually facile solvolysis of primary tosylates. A case for participation by the N‐nitroso group. J. Org. Chem. 44:2718‐2722. | |
| Koizumi, M., Koga, R., Hotoda, H., Momota, K., Ohmine, T., Furukawa, H., Agatsuma, T., Nishigaki, T., Abe, K., Kosaka, T., Tsutsumi, S., Sone, J., Kaneko, M., Kimura, S., and Shimada, K. 1997. Biologically active oligodeoxyribonucleotides—IX. Synthesis and anti‐HIV‐1 activity of hexadeoxyribonucleotides, TGGGAG, bearing 3′‐ and 5′‐end‐modification. Bioorg. Med. Chem. 5:2235‐2243. | |
| Krieg, A.M. 2002. CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol. 20:709‐760. | |
| Poijärvi, P., Oivanen, M., and Lönnberg, H. 2004. Towards oligonucleotide pro‐drugs: 2,2‐Bis(ethoxycarbonyl) and 2‐(alkylaminocarbonyl)‐2‐cyano substituted 3‐(pivaloyloxy)propyl groups as biodegradable protecting groups for internucleosidic phosphoromonothioate linkages. Lett. Org. Chem. 1:183‐188. | |
| Yakubov, L.A., Deeva, E.A., Zarytova, V.F., Ivanova, E.M, Ryte, A.S., Yurchenko, L.V., and Vlassov, V.V. 1989. Mechanism of oligonucleotide uptake by cells: Involvement of specific receptors? Proc. Natl. Acad. Sci. U.S.A. 86:6454‐6458. |
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library
![ENOX1/ENOX1蛋白Recombinant Human Ecto-NOX disulfide-thiol exchanger 1 (ENOX1)重组蛋白Candidate growth-related and time keeping constitutive hydroquinone [NADH] oxidase蛋白](https://img1.dxycdn.com/p/s14/2024/0914/386/8235194321829384381.jpg!wh200)
